(Q37979498)

English

Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit